Abbott CEO "fully confident" in future pharma spin-out chief, despite resume fuss
Personnel Moves
Stryker details executive shuffle, names interim CFO
Different takes on Abbott exec’s “misstated” creds | MassDevice.com On Call
MASSDEVICE ON CALL — Analysts are ambivalent about the importance of Abbott (NYSE:ABT) executive Richard Gonzalez’s "misstated" educational background.
Gonzalez may gain some merit as the quintessential self-made man, given recently uncovered reports that he didn’t have the college degrees that Abbott had attributed to him for years.
Former Stryker CEO MacMillan lauds new chief: “He’s by far the best choice”
Former Stryker (NYSE:SYK) CEO Stephen MacMillan had nothing but praise for successor Kevin Lobo, whose appointment to the corner office at the orthopedic giant was announced today.
He wasn’t surprised that Stryker picked Lobo, MacMillan told MassDevice.com at when we caught up with him today at industry lobby AdvaMed’s annual conference in Boston.
Stryker appoints Lobo CEO, CFO Hartman prepares to leave
ReCor Medical adds 4 to expand its medical advisory board | Personnel Moves
Abbott’s new pharma spin-out chief’s college credentials “misstated”
Contrary to previous company statements, longtime Abbott executive and new pharmaceutical spin-off chief Richard Gonzalez never finished college, the company confirmed today.
An administrative error resulted in regulatory filings stating that Gonzalez had earned a bachelor’s degree from the University of Houston and master’s degree from the University of Miami. Although Gonzalez attended both institutions, he didn’t graduate from either. Abbott has since updated the information on its corporate website to address the error.